Ultragenyx Pharmaceutical (Rare Pediatric Disease Priority Review Voucher) is Buildings and Property in United States that focus on healthcare voucher business. They cover business area such as United state, new drug.
-
Healthcare Voucher
-
60 Leveroni Court
Novato, CA 94949
United States
Private
United statenew drug
* We use standard office opening hours in near Ultragenyx Pharmaceutical (Rare Pediatric Disease Priority Review Voucher)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ultragenyx Pharmaceutical (Rare Pediatric Disease Priority Review Voucher) is Buildings and Property business from United States that founded in - ( years old in ), Ultragenyx Pharmaceutical (Rare Pediatric Disease Priority Review Voucher) business is focusing on Healthcare Voucher.
Ultragenyx Pharmaceutical (Rare Pediatric Disease Priority Review Voucher) headquarter office and corporate office address is located in 60 Leveroni Court Novato, CA 94949 United States.
Ultragenyx Pharmaceutical (Rare Pediatric Disease Priority Review Voucher) was founded in United States.
In , Ultragenyx Pharmaceutical (Rare Pediatric Disease Priority Review Voucher) is currently focus on healthcare voucher sector.
Above is snippet of Google Trends for "healthcare voucher" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ultragenyx Pharmaceutical (Rare Pediatric Disease Priority Review Voucher), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.